3SBIO(01530),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01530 3SBIO

Not Yet Opened 06-26 16:08:11

15.910

-0.150

-0.93%

High16.740	Low15.800	Vol25.42M
Open16.280	D1 Closing16.060	Amplitude5.85%
Mkt Cap40.25B	Tradable Cap40.25B	Total Shares2.53B
T/O408.01M	T/O Rate1.00%	Tradable Shares2.53B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"3SBIO","latestPrice":15.91,"timestamp":1782461291004,"preClose":16.06,"halted":0,"volume":25420952,"delay":0,"changeRate":-0.009339975093399663,"floatShares":2530000000,"shares":2530000000,"eps":3.954170496431652,"marketStatus":"Not Yet Opened","change":-0.15,"latestTime":"06-26 16:08:11","open":16.28,"high":16.74,"low":15.8,"amount":408010897,"amplitude":0.058531,"askPrice":15.91,"askSize":43000,"bidPrice":15.89,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":3.954170496431652,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":0,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":16.06,"dividendRate":0.015713,"openAndCloseTimeList":[[1782437400000,1782446400000],[1782450000000,1782460800000]],"volumeRatio":0.8029194701066472,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530/tweets","defaultTab":"tweets","newsList":[{"id":"1117725539","title":"3SBio AGM Endorses HK$0.25 Final Dividend, Passes All Resolutions and Appoints KPMG as Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1117725539","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117725539?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:29","pubTimestamp":1782383347,"startTime":"0","endTime":"0","summary":"3SBio Inc. held its Annual General Meeting on 25 June 2026, with all six directors present in person or electronically. Based on the poll count supervised by Computershare Hong Kong Investor...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130744250","title":"Movement Alert｜3SBio Rises 5.23% in Regular Trading, CMB International Recommends as Bottom Opportunity with Company Buyback Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1130744250","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130744250?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:55","pubTimestamp":1782266124,"startTime":"0","endTime":"0","summary":"On June 24, 3SBio rose 5.23% in regular trading, trading at HKD 17.3/share, with turnover of HKD 181 million. Multiple catalysts converged to drive the stock higher.On the news front, CMB...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142820000","title":"3SBIO Executes Share Buyback, Spending HK$15.7 Million on June 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1142820000","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142820000?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:26","pubTimestamp":1782131195,"startTime":"0","endTime":"0","summary":"3SBIO (HKEX: 01530) has announced a share repurchase transaction.The company disclosed that on June 22, 2026, it utilized approximately HK$15.7 million to buy back 1.013 million of its own shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1593","HK0000165453.HKD","BK1583","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104234810","title":"3SBio Executes HKD 15.72 Million Share Buyback, Free-Float Down 0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104234810","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104234810?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:23","pubTimestamp":1782131013,"startTime":"0","endTime":"0","summary":"On 22 June 2026, 3SBio Inc. repurchased 1.01 million ordinary shares on the Hong Kong Stock Exchange, spending HKD 15.72 million in aggregate. The purchase price ranged between HKD 15.40 and HKD...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147911226","title":"Movement Alert｜3SBio Rises 5.04% in Regular Trading, Biotech Sector Collective Rebound Combined with Continuous Institutional Accumulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1147911226","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147911226?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:28","pubTimestamp":1781749717,"startTime":"0","endTime":"0","summary":"On June 18, 3SBio rose 5.04% in regular trading, trading at HK$16.83/share, with turnover of HK$159 million. The rally was driven by a broad-based rebound in the biotechnology sector alongside...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137912142","title":"Movement Alert｜3SBio Falls 5.79% in Regular Trading, Biotech Sector Under Broad Pressure as Short-Selling Ratio Climbs","url":"https://stock-news.laohu8.com/highlight/detail?id=1137912142","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137912142?lang=en_us&edition=fundamental","pubTime":"2026-06-16 10:01","pubTimestamp":1781575308,"startTime":"0","endTime":"0","summary":"On June 16, 3SBio fell 5.79% in regular trading, trading at HK$16.11/share, with turnover of approximately HK$130 million. The decline came amid broad weakness across the biotechnology sector coupled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160651559","title":"3SBIO Sees Major Share Purchase by Fullgoal Fund Management","url":"https://stock-news.laohu8.com/highlight/detail?id=1160651559","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160651559?lang=en_us&edition=fundamental","pubTime":"2026-06-15 07:20","pubTimestamp":1781479234,"startTime":"0","endTime":"0","summary":"Recent data from the Hong Kong Stock Exchange reveals a significant transaction involving a leading biopharmaceutical firm.On June 10th, Fullgoal Fund Management Co., Ltd. increased its stake in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1593","BK1161","BK1583","HK0000165453.HKD","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136328133","title":"3SBIO Sees Major Share Purchase by Fund Manager at HK$16.28 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1136328133","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136328133?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:50","pubTimestamp":1781268619,"startTime":"0","endTime":"0","summary":"According to the latest information from the Hong Kong Stock Exchange, on June 10th, a significant share purchase was made in 3SBIO (HKEX: 01530).Huitianfu Fund Management Co., Ltd. acquired 636,500...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1583","HK0000165453.HKD","BK1161","BK1593","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642728474","title":"Jing Lou Spends CN¥7.9m On 3SBio Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2642728474","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642728474?lang=en_us&edition=fundamental","pubTime":"2026-06-11 07:15","pubTimestamp":1781133346,"startTime":"0","endTime":"0","summary":"3SBio Inc. ( HKG:1530 ) shareholders (or potential shareholders) will be happy to see that the Co-Founder, Jing Lou...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/jing-lou-spends-cn79m-on-3sbio-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/jing-lou-spends-cn79m-on-3sbio-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01530","BK1161","BK1593","HK0000165453.HKD","BK1583","CN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158758327","title":"3SBIO Shares Surge Over 6% in Afternoon Trading Following Chairman's Share Purchase Worth Approximately HK$7.87 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1158758327","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158758327?lang=en_us&edition=fundamental","pubTime":"2026-06-10 14:02","pubTimestamp":1781071353,"startTime":"0","endTime":"0","summary":"Shares of 3SBIO (01530) rose more than 7% during the trading session. At the time of writing, the stock is up 5.97%, trading at HK$16.33 with a turnover of HK$578 million. Latest data from the Hong...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","BK1593","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160330580","title":"Movement Alert｜3SBio Rises 5.32% in Regular Trading, Chairman Stake Increase Combined with Medical Insurance Catalog Adjustment Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1160330580","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160330580?lang=en_us&edition=fundamental","pubTime":"2026-06-10 11:26","pubTimestamp":1781062014,"startTime":"0","endTime":"0","summary":"On June 10, 3SBio rose 5.32% in regular trading, trading at HK$16.4/share, with trading volume of approximately HK$300 million. The stock had previously touched its 52-week low of HK$15.50.Multiple...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146789511","title":"3SBIO Chairman and CEO Lou Jing Acquires Additional 516,000 Shares at HK$15.2497 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1146789511","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146789511?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:26","pubTimestamp":1781011575,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on June 8th, Chairman and Chief Executive Officer Lou Jing increased his holdings in 3SBIO (HKEX: 01530) by 516,000 shares. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","01530","EWH","BK1593","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166354309","title":"Innovative Drug Stocks Under Broad Selling Pressure as Liquidity Tightening Weighs on Valuations; Analysts View BINSA Bill Impact as Sentiment-Driven","url":"https://stock-news.laohu8.com/highlight/detail?id=1166354309","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166354309?lang=en_us&edition=fundamental","pubTime":"2026-06-08 15:16","pubTimestamp":1780903001,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing widespread declines. At the time of writing, Innovent Bio (01801) shares fell 4.9% to HK$72.85. 3SBIO (01530) dropped 3.44% to HK$15.14. SBP Group...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU2097828805.USD","BK4588","LU1152091168.USD","LU0455707207.USD","BK1515","BK1521","LU0072913022.USD","LU0140636845.USD","LU1008478684.HKD","LU1226287792.SGD","LU1993786604.SGD","LU2242644610.SGD","IE0008369823.USD","LU0315179316.USD","BK1574","01530","LU1813983027.USD","LU1951186391.HKD","VXUS","BK1191","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1152091754.HKD","BK1583","IE0008368742.USD","01801","IE00B031HY20.USD","LU1226287529.USD","LU1226287875.USD","LU1960683339.HKD","LU2097828631.EUR","LU2328871848.SGD","159992","LU2039709279.SGD","01177","IE00BZ08YS42.EUR","LU1226288253.USD","LU2097828557.USD","LU0880133367.SGD","01093","LU1328277881.USD","LU2097828474.EUR","SG9999004220.SGD","BK1161","IE00B543WZ88.USD","LU0326950275.SGD","LU0501845795.SGD","BK1589","LU0502904849.HKD","LU1969619763.USD","LU0314109678.HKD","BK4585","BK1593","LU1807302812.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU2488822045.USD","LU0067412154.USD","HK0000165453.HKD","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161906229","title":"3SBIO Experiences Shareholding Reduction by China Universal Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1161906229","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161906229?lang=en_us&edition=fundamental","pubTime":"2026-06-08 08:00","pubTimestamp":1780876840,"startTime":"0","endTime":"0","summary":"New data from the Hong Kong Stock Exchange reveals a recent transaction involving a major shareholder.On June 2nd, China Universal Fund reduced its stake in 3SBIO (HKEX: 01530) by 2.162 million...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","01530","BK1161","BK1583","HK0000165453.HKD","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160289463","title":"3SBIO Shares Reduced by Fund Manager, 2.16 Million Units Sold at Average Price of HK$17.15","url":"https://stock-news.laohu8.com/highlight/detail?id=1160289463","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160289463?lang=en_us&edition=fundamental","pubTime":"2026-06-05 21:15","pubTimestamp":1780665304,"startTime":"0","endTime":"0","summary":"Recent data from the Hong Kong Stock Exchange reveals that on June 2nd, a fund manager reduced its stake in 3SBIO (HKEX: 01530) by 2.162 million shares.The shares were disposed of at an average price...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","HK0000165453.HKD","EWH","BK1593","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123160211","title":"3SBio (01530) Calls 25 Jun 2026 AGM; Seeks 20% Share-Issue Mandate, 10% Buy-Back Power, HK$0.25 Final Dividend and Auditor Shift to KPMG","url":"https://stock-news.laohu8.com/highlight/detail?id=1123160211","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123160211?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:45","pubTimestamp":1780476321,"startTime":"0","endTime":"0","summary":"3SBio Inc. has issued a circular convening its annual general meeting (AGM) for 25 June 2026 in Shenyang, where shareholders will vote on a series of key resolutions. General & Repurchase Mandates...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972712","title":"3SBio announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972712","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640972712?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:33","pubTimestamp":1780475616,"startTime":"0","endTime":"0","summary":"3SBio will hold its annual general meeting in Shenyang, China on June 25, 2026.Shareholders will vote to adopt the audited consolidated financial statements for the year ended Dec. 31, 2025.Proposals include re-electing independent non-executive directors Pu Tianruo, Ng Joo Yeow Gerry; board authority to set director remuneration.Final dividend proposal of HK$ 0.25 per ordinary share, payable to shareholders on the register on July 27, 2026.Items also include appointing KPMG as auditor; mandates for share issuance and share repurchases, with an extension tied to buybacks.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3SBio Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDLbxbwlp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1593","BK1583","01530","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148492659","title":"Stock Track | 3SBIO Plummets 7.40% Intraday as Biotech Sector Sees Profit-Taking After ASCO Catalyst Run-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1148492659","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148492659?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:44","pubTimestamp":1780364661,"startTime":"0","endTime":"0","summary":"3SBIO's stock plummeted 7.40% during intraday trading on Tuesday, marking a significant reversal from recent gains.The sharp decline reflects broad-based profit-taking across the biotechnology sector...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176280574","title":"Movement Alert｜3SBio Falls 5.62% in Regular Trading, Biotech Sector Pulls Back After ASCO Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1176280574","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176280574?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:42","pubTimestamp":1780364527,"startTime":"0","endTime":"0","summary":"On June 2, 3SBio fell 5.62% in regular trading, trading at HK$17.12/share, with trading volume of HK$133 million. The decline follows two consecutive sessions of strong gains driven by ASCO Annual...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168285835","title":"Stock Track | 3SBIO Soars 6.00% at Market Open on Positive ASCO Clinical Data and Pfizer Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1168285835","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168285835?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:37","pubTimestamp":1780277839,"startTime":"0","endTime":"0","summary":"3SBIO's stock price soared 6.00% at market open on Monday, driven by positive clinical data presentations and a major licensing agreement.The biopharmaceutical company presented impressive clinical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.1474},{"period":"3month","weight":-0.3365},{"period":"6month","weight":-0.3852},{"period":"1year","weight":-0.2693},{"period":"ytd","weight":-0.342}],"compareEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1049},{"period":"3month","weight":-0.0914},{"period":"6month","weight":-0.1219},{"period":"1year","weight":-0.068},{"period":"ytd","weight":-0.1154}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.00666},{"month":2,"riseRate":0.454545,"avgChangeRate":0.00178},{"month":3,"riseRate":0.818182,"avgChangeRate":0.113214},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.011081},{"month":5,"riseRate":0.636364,"avgChangeRate":0.080954},{"month":6,"riseRate":0.727273,"avgChangeRate":0.020528},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.045323}],"exchange":"SEHK","name":"3SBIO","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"3SBIO(01530),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 3SBIO(01530) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"3SBIO,01530,3SBIO股票,3SBIO股票老虎,3SBIO股票老虎国际,3SBIO行情,3SBIO股票行情,3SBIO股价,3SBIO股市,3SBIO股票价格,3SBIO股票交易,3SBIO股票购买,3SBIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"3SBIO(01530),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 3SBIO(01530) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}